Latest News
A distinct intestinal microenvironment linked to bowel habits in patients with irritable bowel syndrome.
At Calmino Group AB, we believe in “Continuous learning leads to continuous growth” through new research and collaborations. Our latest research abstract titled “A distinct intestinal microenvironment linked to bowel habits in patients with irritable bowel syndrome”...
Calmino Group Announces the Launch of PROIBS® in Greece!
We are proud to announce that PROIBS® is now available in Greece following our partnership with Pharmaserve Lilly. PROIBS® is a certified medical device product for the treatment of symptoms related to IBS such as abdominal pain, bloating and changes in bowel...